Simon Herrington
Professor of Molecular Cancer Pathology

- Cancer Research UK Edinburgh Centre
- MRC Institute of Genetics & Cancer
Contact details
- Tel: +44 (0)131 651 8690
- Email: Simon.Herrington@ed.ac.uk
Address
- Street
-
Cancer Research UK Edinburgh Centre
MRC Institute of Genetics & Cancer
The University of Edinburgh
Western General Hospital
Crewe Road South - City
- Edinburgh
- Post code
- EH4 2XR
Background
Simon Herrington graduated in biochemistry with honours from the University of Cambridge in 1982 and medicine with honours from the University of London in 1985. He trained in Internal Medicine (MRCP 1988) and then became a CRC clinical research fellow in the Nuffield Department of Pathology, University of Oxford, receiving his DPhil in 1991. He was appointed clinical lecturer in pathology in Oxford where he completed his training in clinical cellular pathology, gaining the MRCPath in 1994. He was appointed clinical senior lecturer and consultant in pathology at the University of Liverpool in 1995 and was promoted to a Personal Chair in 1999. In 2003, he was appointed to the Chair of Pathology at the University of St Andrews, moving to the Chair of Pathology at the University of Dundee in 2010 and the Chair of Molecular Cancer Pathology at the University of Edinburgh in 2015. He also works as a consultant pathologist, specialising in gynaecological pathology, was co-editor of the 4th and 5th Editions of the WHO Classification of Tumours of Female Reproductive Organs and edited the 15th and 16th Editions of Muir’s Textbook of Pathology. He is a past President of the International Society of Gynecological Pathologists, and is Editor in Chief of the Journal of Pathology and the Journal of Pathology: Clinical Research.
-
Gynecologic Cancer InterGroup consensus recommendations on clinical research in ovarian cancer
In:
The Lancet Oncology
Research output: Contribution to Journal › Article (Accepted/In press) -
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial
In:
The Lancet
Research output: Contribution to Journal › Article (Published) -
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
In:
Cancers
DOI: https://doi.org/10.3390/cancers13225839
Research output: Contribution to Journal › Article (Published) -
The IARC perspective on Cervical Cancer Screening
In:
New England Journal of Medicine
DOI: https://doi.org/10.1056/NEJMsr2030640
Research output: Contribution to Journal › Article (E-pub ahead of print) -
A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma
In:
Journal of Pathology
DOI: https://doi.org/10.1002/path.5769
Research output: Contribution to Journal › Article (E-pub ahead of print)